Amitriptyline in the treatment of primary headaches (Q43265634)

17 November 2017

title

Amitriptyline in the treatment of primary headaches (English)

1 reference

17 November 2017

1 reference

1 reference

Lars Bendtsen

0 references

1 March 2003

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

17 November 2017

published in

1 reference

17 November 2017

1 reference

17 November 2017

1 reference

17 November 2017

page(s)

165-173

1 reference

Epidemiology of headache in a general population--a prevalence study.

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Migraine in the United States: epidemiology and patterns of health care use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Pathophysiological mechanisms of tension-type headache: a review of epidemiological and experimental studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Central sensitization in tension-type headache--possible pathophysiological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Migraine and tension-type headache are not separate disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Clinical and pathophysiological observations in migraine and tension-type headache explained by integration of vascular, supraspinal and myofascial inputs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Migraine: preventive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Preventive treatment of migraine: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Migraine prophylactic drugs: proof of efficacy, utilization and cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Advances in pharmacological treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

TREATMENT OF CHRONIC TENSION HEADACHE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Amitriptyline in Migraine Prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Migraine prophylaxis. A comparison of propranolol and amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

How do the currently used prophylactic agents work in migraine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Is the 5-HT(7) receptor involved in the pathogenesis and prophylactic treatment of migraine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Amitriptyline is effective in chronic but not in episodic tension-type headache: pathogenetic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Peripheral antinociceptive action of amitriptyline in the rat formalin test: involvement of adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Guidelines for trials of drug treatments in tension-type headache. First edition: International Headache Society Committee on Clinical Trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Chronic tension headache--treated with amitriptyline--a double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity but does not alter pericranial muscle activity readings

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Effectiveness of amitriptyline in the prophylactic management of childhood headaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

New and emerging prophylactic agents for migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.2.165

21 January 2018

Identifiers

DOI

10.1586/14737175.3.2.165

1 reference

17 November 2017

1 reference